Karen Smith

Karen Smith

DirectoratSkye Bioscience· In proxies 2024–2025

Karen Smith sits on 2 public boards.

Experience

  1. Skye BiosciencePublic company · 2 yr
    • Director2024 – Present · 2 yrStock in role -99%
  2. Aurinia Pharmaceuticals, Inc.Public company
    • Director? – PresentNo stock prices for these years
  3. Sangamo Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?